Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
35.20
-0.20 (-0.56%)
Mar 27, 2026, 5:00 PM CET
Market Cap649.78M -21.3%
Revenue (ttm)373.90M +11.8%
Net Income-2.89M
EPS-0.16
Shares Out18.36M
PE Ration/a
Forward PE40.69
Dividendn/a
Ex-Dividend Daten/a
Volume10,402
Average Volume20,474
Open34.80
Previous Close35.40
Day's Range34.00 - 35.40
52-Week Range26.50 - 49.40
Beta-0.03
RSI22.18
Earnings DateMar 31, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements